Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
03:59:53 2026-06-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+28.41% | -10.38% |
| Market Cap | 254M 224M 212M 191M 361M 24.35B 365M 2.54B 976M 12.45B 954M 933M 39.91B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 350M 308M 292M 264M 497M 33.56B 503M 3.49B 1.34B 17.16B 1.31B 1.29B 55.01B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.73x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +28.41% | ||
| Current month | +37.68% | ||
| 1 month | +20.46% | ||
| 3 months | +9.74% | ||
| 6 months | -0.73% | ||
| Current year | -10.38% |
| 1 week | 0.14 |  | 0.21 |
| 1 month | 0.14 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 0.94 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/29/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 8/9/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +28.41% | -14.65% | -77.47% | 254M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.45% | +0.98% | +27.46% | +80.51% | 60.14B | |
| -2.38% | -1.54% | +4.98% | +33.46% | 48.15B | |
| -1.51% | -3.81% | +29.81% | +36.45% | 44.25B | |
| +1.51% | +5.16% | +358.31% | +703.13% | 43.99B | |
| -0.45% | +1.07% | +8.55% | +103.83% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -2.90% | -8.57% | -24.55% | +338.04% | 24.93B | |
| Average | +0.66% | +1.77% | +48.72% | +138.61% | 39.71B | |
| Weighted average by Cap. | +0.79% | +1.83% | +59.95% | +153.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.29M 32.48M 29.33M 55.27M 3.73B 55.99M 389M 150M 1.91B 146M 143M 6.12B |
| Net income | - | - |
| Net Debt | 96.08M 84.61M 80.16M 72.37M 136M 9.21B 138M 959M 369M 4.71B 361M 353M 15.1B | 125M 110M 104M 94.11M 177M 11.98B 180M 1.25B 480M 6.12B 469M 459M 19.63B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | $0.1489 | -0.40% | 3,438,311 |
| 26-09-29 | $0.1495 | -1.97% | 4,896,470 |
| 26-09-28 | $0.1525 | -4.69% | 3,918,070 |
| 26-09-25 | $0.1600 | +0.25% | 2,348,226 |
| 26-09-24 | $0.1596 | -0.03% | 2,391,461 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1489USD
Average target price
1.000USD
Spread / Average Target
+571.59%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
